This podcast feature a fireside chat between Dr Ira Mellman, PICI and Dr Axel Hoos, Former CEO, Scorpion Therapeutics from the 2026 Immuno-Oncology 360° conference. Drawing on Dr Mellman’s extensive experience and current work at the Parker Institute for Cancer Immunotherapy, this conversation provides:
- Insight into the scientific and clinical trajectory of immuno-oncology
- Perspectives on the evolving role of collaboration and innovative partnership models like PICI
- Discussion of the key opportunities and challenges shaping IO innovation at scale
- A visionary outlook on what the next chapter of immuno-oncology could look like
To learn more about the IO360° Summit, please visit https://www.io360summit.com/